Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Amortizatization of Intangibles: 2022-2025

Historic Amortizatization of Intangibles for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $194,000.

  • Orchestra BioMed Holdings' Amortizatization of Intangibles fell 45.51% to $194,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $722,000, marking a year-over-year decrease of 62.16%. This contributed to the annual value of $1.5 million for FY2024, which is 60.70% down from last year.
  • Orchestra BioMed Holdings' Amortizatization of Intangibles amounted to $194,000 in Q3 2025, which was up 29.33% from $150,000 recorded in Q2 2025.
  • Orchestra BioMed Holdings' 5-year Amortizatization of Intangibles high stood at $1.1 million for Q3 2023, and its period low was $132,000 during Q1 2022.
  • Its 3-year average for Amortizatization of Intangibles is $528,273, with a median of $356,000 in 2024.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Amortizatization of Intangibles spiked by 700.00% in 2023, and later tumbled by 75.04% in 2025.
  • Quarterly analysis of 4 years shows Orchestra BioMed Holdings' Amortizatization of Intangibles stood at $181,000 in 2022, then spiked by 252.49% to $638,000 in 2023, then slumped by 63.79% to $231,000 in 2024, then plummeted by 45.51% to $194,000 in 2025.
  • Its Amortizatization of Intangibles was $194,000 in Q3 2025, compared to $150,000 in Q2 2025 and $147,000 in Q1 2025.